Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
89 hedge funds and large institutions have $201M invested in Pernix Therapeutics Holdings, Inc. in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 8 closing their positions.
338% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 8
132% more capital invested
Capital invested by funds: $86.7M → $201M (+$114M)
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
41% more funds holding
Funds holding: 63 → 89 (+26)
38% less call options, than puts
Call options by funds: $3.17M | Put options by funds: $5.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
+$12.3M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$11.1M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$7.88M |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
+$7.51M |
| 5 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
+$3.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sageview Capital
Greenwich,
Connecticut
|
-$11.9M |
| 2 |
O
OrbiMed
New York
|
-$6.54M |
| 3 |
EWP
Edmunds White Partners
Richmond,
Virginia
|
-$3.76M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.04M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$696K |
PTX Hedge Fund Activity: Q2 2014 in Review
89 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q2 2014, worth a combined $201M — up 132% from $86.7M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new PTX positions and 8 closed out — a net gain of 27 holders — while 32 added to existing stakes and 15 trimmed.
The largest buyer was Aisling Capital, opening a new position worth an estimated $12.3M. The largest seller was Sageview Capital, exiting entirely with an estimated $11.9M sold.
- 89 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q2 2014, up from 63 in Q1 2014.
- Funds reported $201M of Pernix Therapeutics Holdings, Inc. stock for Q2 2014, up 132% quarter-over-quarter.
- 35 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q2 2014 and 8 closed out, a net change of +27 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q2 2014 was Aisling Capital, an estimated $12.3M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q2 2014 was Sageview Capital, an estimated $11.9M sold.
Based on aggregated 13F filings for Q2 2014.